|
業務類別
|
Biotechnology |
|
業務概覽
|
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development. |
| 公司地址
| 180 Varick Street, New York, NY, USA, 10014 |
| 電話號碼
| +31 207932536 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.ataibeckley.com |
| 員工數量
| 63 |
| Dr. Glenn Frank Short, PhD |
Chief Scientific Officer |
-- |
21/04/2025 |
| Mr. Srinivas G. Rao, M.D.,PhD |
Director, Chief Executive Officer, Interim Managing Director and Managing Director |
美元 568.33K |
21/05/2025 |
| Mr. Kevin James Craig |
Chief Medical Officer |
-- |
21/04/2025 |
| Dr. Gerd Kochendoerfer, PhD |
Chief Operating Officer |
-- |
10/01/2025 |
| Ms. Anne Nagengast Johnson |
Director, Chief Accounting Officer, Managing Director and Chief Financial Officer |
美元 415.00K |
21/05/2025 |
| Mr. Christian Angermayer |
Chairman of the Supervisory Board |
-- |
21/04/2025 |
|
|
| Mr. John Hoffman |
Member of the Supervisory Board |
21/05/2025 |
| Dr. Scott Braunstein, M.D. |
Member of the Supervisory Board |
21/04/2025 |
| Ms. Sabrina Martucci Johnson |
Member of the Supervisory Board |
21/04/2025 |
| Dr. Amir Kalali,M.D. |
Member of the Supervisory Board |
21/04/2025 |
| Mr. Srinivas G. Rao, M.D.,PhD |
Director, Chief Executive Officer, Interim Managing Director and Managing Director |
21/05/2025 |
| Dr. Laurent Fischer, M.D. |
Member of the Supervisory Board |
21/04/2025 |
| Ms. Andrea Heslin Smiley |
Member of the Supervisory Board |
21/04/2025 |
| Ms. Anne Nagengast Johnson |
Director, Chief Accounting Officer, Managing Director and Chief Financial Officer |
21/05/2025 |
| Mr. Christian Angermayer |
Chairman of the Supervisory Board |
21/04/2025 |
|
|
|
|
